Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 143 for Ovarian

Edit search filters
  1. A First-in-Human Study Of MEN2501 In Participants With Platinum-Resistant Ovarian Cancer

    Rochester, MN

  2. Avatar-Directed Chemotherapy In Treating Patients With Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Study To Compare The Safety And Effectiveness Of Treatment Combinations In Patients With Recurrent Ovarian Cancer

    Rochester, MN

  4. Olaparib Monotherapy In Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

    Rochester, MN

  5. OTL38 For Intra-operative Imaging Of Folate Receptor Positive Ovarian Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. An Investigational Immuno-therapy Study To Assess The Safety, Tolerability And Effectiveness Of Anti-LAG-3 With And Without Anti-PD-1 In The Treatment Of Solid Tumors

    Rochester, MN

  7. A Study Of Niraparib In Patients With Ovarian Cancer Who Have Received Three Or Four Previous Chemotherapy Regimens

    Rochester, MN

  8. Study Of The Safety, Pharmacokinetics And Efficacy Of EDO-S101, In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study To Evaluate AVB-S6-500 With Paclitaxel Vs Paclitaxel In Patients With Platinum-resistant Recurrent Ovarian Cancer

    Rochester, MN

  10. A Study Of Niraparib Combined With Pembrolizumab (MK-3475) In Patients Who Have Triple-Negative Breast Cancer Or Ovarian Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer